Literature DB >> 23519045

Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent.

Danielle Baribeau1, Keyghobad Farid Araki.   

Abstract

Bupropion is an antidepressant commonly prescribed as a smoking cessation aid. It has effects on dopamine and norepinephrine, and can lower seizure threshold, particularly in overdose. Several cases of recreational use of bupropion via nasal insufflation have been reported in the literature. Here we describe a first case of intravenous bupropion dependence, with no evidence of resulting seizure activity. This addiction was sustained in part under the the premise of seeking smoking cessation aid. Pharmacokinetic interactions are explored, and the literature with respect to buproprion abuse is reviewed. We propose that bupropion may have stimulant effects amenable to abuse that vary with route of administration. Health care providers may wish to exercise additional caution when prescribing bupropion to unfamiliar patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519045     DOI: 10.1097/ADM.0b013e3182824863

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  11 in total

1.  [Intravenous abuse of bupropione].

Authors:  N Behler; A Lehmann; B Malchow; U Palm
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

2.  Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.

Authors:  Abdelrahman R Shalabi; Donna Walther; Michael H Baumann; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2017-02-27       Impact factor: 4.418

3.  Rates of Anomalous Bupropion Prescriptions in Ontario, Canada.

Authors:  Leah S Steele; Erin M Macdonald; Tara Gomes; Simon Hollands; J Michael Paterson; Muhammad M Mamdani; David N Juurlink
Journal:  Ann Fam Med       Date:  2015 Jul-Aug       Impact factor: 5.166

Review 4.  Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Wim Verbeeck; Geertruida E Bekkering; Wim Van den Noortgate; Cornelis Kramers
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

Review 5.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14

6.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

7.  Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.

Authors:  Evangelia Liakoni; Sabine Müller; Adrian Stoller; Meret Ricklin; Matthias E Liechti; Aristomenis K Exadaktylos
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-03-07       Impact factor: 2.953

8.  Antidepressant Screening Demonstrated Non-Monotonic Responses to Amitriptyline, Amoxapine and Sertraline in Locomotor Activity Assay in Larval Zebrafish.

Authors:  Michael Edbert Suryanto; Gilbert Audira; Boontida Uapipatanakul; Akhlaq Hussain; Ferry Saputra; Petrus Siregar; Kelvin H-C Chen; Chung-Der Hsiao
Journal:  Cells       Date:  2021-03-26       Impact factor: 6.600

9.  Is There a Potential of Misuse for Venlafaxine and Bupropion?

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

Review 10.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.